首页 > 最新文献

Jama-Journal of the American Medical Association最新文献

英文 中文
Electroencephalography-Guided Anesthesia and Delirium in Older Adults. 脑电图引导的麻醉与老年人的谵妄。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 DOI: 10.1001/jama.2024.18662
Shuyang Xiang, Wangning ShangGuan, Xiaocou Wang
{"title":"Electroencephalography-Guided Anesthesia and Delirium in Older Adults.","authors":"Shuyang Xiang, Wangning ShangGuan, Xiaocou Wang","doi":"10.1001/jama.2024.18662","DOIUrl":"https://doi.org/10.1001/jama.2024.18662","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increasing Medicare Savings Program Enrollment-Improving Affordability of Care. 增加医疗保险储蓄计划的注册人数--提高护理的可负担性。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 DOI: 10.1001/jama.2024.21078
Syama R Patel, Dominic A Ruggiero, Eric T Roberts
{"title":"Increasing Medicare Savings Program Enrollment-Improving Affordability of Care.","authors":"Syama R Patel, Dominic A Ruggiero, Eric T Roberts","doi":"10.1001/jama.2024.21078","DOIUrl":"https://doi.org/10.1001/jama.2024.21078","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State Policies Regulating Law Enforcement Access to Prescription Drug Monitoring Program Testosterone Prescription Data. 规范执法部门获取处方药监控计划睾酮处方数据的州政策。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 DOI: 10.1001/jama.2024.20035
Katie McCreedy, Jule von der Heydt, Aanchalika Chauhan, Rajvi Shah, Sunyou Kang, Elizabeth Platt, Leo Beletsky
{"title":"State Policies Regulating Law Enforcement Access to Prescription Drug Monitoring Program Testosterone Prescription Data.","authors":"Katie McCreedy, Jule von der Heydt, Aanchalika Chauhan, Rajvi Shah, Sunyou Kang, Elizabeth Platt, Leo Beletsky","doi":"10.1001/jama.2024.20035","DOIUrl":"10.1001/jama.2024.20035","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525661/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Old Doc. 老医生
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 DOI: 10.1001/jama.2024.14802
Abigail Zuger
{"title":"Old Doc.","authors":"Abigail Zuger","doi":"10.1001/jama.2024.14802","DOIUrl":"https://doi.org/10.1001/jama.2024.14802","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Hyperesthetic Neuralgia" and "Crawly Skin": Poetry and Empathy in Medicine. "过度麻醉性神经痛 "和 "爬行皮肤":医学中的诗歌与移情。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 DOI: 10.1001/jama.2024.15154
Rafael Campo
{"title":"\"Hyperesthetic Neuralgia\" and \"Crawly Skin\": Poetry and Empathy in Medicine.","authors":"Rafael Campo","doi":"10.1001/jama.2024.15154","DOIUrl":"https://doi.org/10.1001/jama.2024.15154","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electroencephalography-Guided Anesthesia and Delirium in Older Adults-Reply. 脑电图引导的麻醉与老年人的谵妄--回复。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 DOI: 10.1001/jama.2024.18665
Alain Deschamps, Michael Avidan, Arbi Ben Abdallah
{"title":"Electroencephalography-Guided Anesthesia and Delirium in Older Adults-Reply.","authors":"Alain Deschamps, Michael Avidan, Arbi Ben Abdallah","doi":"10.1001/jama.2024.18665","DOIUrl":"https://doi.org/10.1001/jama.2024.18665","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parenthood and Paychecks-The Gender Pay Gap in Medicine. 为人父母与薪水--医学界的性别薪酬差距》(Parenthood and Paychecks-The Gender Pay Gap in Medicine)。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-29 DOI: 10.1001/jama.2024.22123
Kyung Mi Kim, Aditya Narayan, Nirav R Shah, Arnold Milstein
{"title":"Parenthood and Paychecks-The Gender Pay Gap in Medicine.","authors":"Kyung Mi Kim, Aditya Narayan, Nirav R Shah, Arnold Milstein","doi":"10.1001/jama.2024.22123","DOIUrl":"https://doi.org/10.1001/jama.2024.22123","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ovarian Aging and Fertility. 卵巢衰老与生育能力
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-29 DOI: 10.1001/jama.2024.18207
David B Seifer, Eve C Feinberg, Albert L Hsu
{"title":"Ovarian Aging and Fertility.","authors":"David B Seifer, Eve C Feinberg, Albert L Hsu","doi":"10.1001/jama.2024.18207","DOIUrl":"https://doi.org/10.1001/jama.2024.18207","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myocardial Fibrosis and Timing of Intervention for Aortic Stenosis. 心肌纤维化与介入治疗主动脉瓣狭窄的时机
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-28 DOI: 10.1001/jama.2024.22853
Robert O Bonow
{"title":"Myocardial Fibrosis and Timing of Intervention for Aortic Stenosis.","authors":"Robert O Bonow","doi":"10.1001/jama.2024.22853","DOIUrl":"https://doi.org/10.1001/jama.2024.22853","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial. 早期干预无症状重度主动脉瓣狭窄和心肌纤维化患者:EVOLVED 随机临床试验。
IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-28 DOI: 10.1001/jama.2024.22730
Krithika Loganath, Neil J Craig, Russell J Everett, Rong Bing, Vasiliki Tsampasian, Patrycja Molek, Simona Botezatu, Saadia Aslam, Steff Lewis, Catriona Graham, Audrey C White, Tom MacGillivray, Christopher E Tuck, Phillip Rayson, Denise Cranley, Sian Irvine, Ruth Armstrong, Lynsey Milne, Calvin W L Chin, Graham S Hillis, Timothy Fairbairn, John P Greenwood, Richard Steeds, Stephen J Leslie, Chim C Lang, Chiara Bucciarelli-Ducci, Nikhil V Joshi, Vijay Kunadian, Vassilios S Vassiliou, Jason N Dungu, Sandeep S Hothi, Nicholas Boon, Sanjay K Prasad, Niall G Keenan, Dana Dawson, Thomas A Treibel, Mani Motwani, Christopher A Miller, Nicholas L Mills, Ronak Rajani, David P Ripley, Gerry P McCann, Bernard Prendergast, Anvesha Singh, David E Newby, Marc R Dweck

Importance: Development of myocardial fibrosis in patients with aortic stenosis precedes left ventricular decompensation and is associated with an adverse long-term prognosis.

Objective: To investigate whether early valve intervention reduced the incidence of all-cause death or unplanned aortic stenosis-related hospitalization in asymptomatic patients with severe aortic stenosis and myocardial fibrosis.

Design, setting, and participants: This prospective, randomized, open-label, masked end point trial was conducted between August 2017 and October 2022 at 24 cardiac centers across the UK and Australia. Asymptomatic patients with severe aortic stenosis and myocardial fibrosis were included. The final date of follow-up was July 26, 2024.

Intervention: Early valve intervention with transcatheter or surgical aortic valve replacement or guideline-directed conservative management.

Main outcomes and measures: The primary outcome was a composite of all-cause death or unplanned aortic stenosis-related hospitalization in a time-to-first-event intention-to-treat analysis. There were 9 secondary outcomes, including the components of the primary outcome and symptom status at 12 months.

Results: The trial enrolled 224 eligible patients (mean [SD] age, 73 [9] years; 63 women [28%]; mean [SD] aortic valve peak velocity of 4.3 [0.5] m/s) of the originally planned sample size of 356 patients. The primary end point occurred in 20 of 113 patients (18%) in the early intervention group and 25 of 111 patients (23%) in the guideline-directed conservative management group (hazard ratio, 0.79 [95% CI, 0.44-1.43]; P = .44; between-group difference, -4.82% [95% CI, -15.31% to 5.66%]). Of 9 prespecified secondary end points, 7 showed no significant difference. All-cause death occurred in 16 of 113 patients (14%) in the early intervention group and 14 of 111 (13%) in the guideline-directed group (hazard ratio, 1.22 [95% CI, 0.59-2.51]) and unplanned aortic stenosis hospitalization occurred in 7 of 113 patients (6%) and 19 of 111 patients (17%), respectively (hazard ratio, 0.37 [95% CI, 0.16-0.88]). Early intervention was associated with a lower 12-month rate of New York Heart Association class II-IV symptoms than guideline-directed conservative management (21 [19.7%] vs 39 [37.9%]; odds ratio, 0.37 [95% CI, 0.20-0.70]).

Conclusions and relevance: In asymptomatic patients with severe aortic stenosis and myocardial fibrosis, early aortic valve intervention had no demonstrable effect on all-cause death or unplanned aortic stenosis-related hospitalization. The trial had a wide 95% CI around the primary end point, with further research needed to confirm these findings.

Trial registration: ClinicalTrials.gov Identifier: NCT03094143.

重要性:主动脉瓣狭窄患者的心肌纤维化发生在左心室失代偿之前,与不良的长期预后有关:目的:研究早期瓣膜介入是否能降低无症状的重度主动脉瓣狭窄和心肌纤维化患者的全因死亡或主动脉瓣狭窄相关的非计划住院的发生率:这项前瞻性、随机、开放标签、掩盖终点的试验于2017年8月至2022年10月期间在英国和澳大利亚的24个心脏中心进行。试验纳入了严重主动脉瓣狭窄和心肌纤维化的无症状患者。最终随访日期为2024年7月26日:干预措施:经导管主动脉瓣置换术或外科主动脉瓣置换术的早期瓣膜干预,或指南指导下的保守治疗:主要结果是全因死亡或与主动脉瓣狭窄相关的计划外住院的复合结果。共有 9 项次要结果,包括主要结果的组成部分和 12 个月时的症状状况:试验招募了 224 名符合条件的患者(平均 [SD] 年龄 73 [9] 岁;63 名女性 [28%];平均 [SD] 主动脉瓣峰值速度 4.3 [0.5] m/s),原计划样本量为 356 名患者。在早期干预组的 113 名患者中,有 20 人(18%)出现了主要终点;在指南指导的保守治疗组的 111 名患者中,有 25 人(23%)出现了主要终点(危险比为 0.79 [95% CI,0.44-1.43];P = .44;组间差异为-4.82% [95% CI,-15.31% 至 5.66%])。在 9 个预先指定的次要终点中,有 7 个无显著差异。早期干预组 113 例患者中有 16 例(14%)发生全因死亡,指南指导组 111 例患者中有 14 例(13%)发生全因死亡(危险比为 1.22 [95% CI, 0.59-2.51]),113 例患者中有 7 例(6%)发生计划外主动脉瓣狭窄住院,111 例患者中有 19 例(17%)发生计划外主动脉瓣狭窄住院(危险比为 0.37 [95% CI, 0.16-0.88])。与指南指导下的保守治疗(21 [19.7%] vs 39 [37.9%];几率比,0.37 [95% CI,0.20-0.70])相比,早期干预与较低的 12 个月纽约心脏病协会 II-IV 级症状发生率相关:对于无症状的重度主动脉瓣狭窄和心肌纤维化患者,早期主动脉瓣介入治疗对全因死亡或主动脉瓣狭窄相关的意外住院没有明显影响。该试验的主要终点的95% CI较宽,需要进一步研究来证实这些结果:试验注册:ClinicalTrials.gov Identifier:试验注册:ClinicalTrials.gov Identifier:NCT03094143。
{"title":"Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial.","authors":"Krithika Loganath, Neil J Craig, Russell J Everett, Rong Bing, Vasiliki Tsampasian, Patrycja Molek, Simona Botezatu, Saadia Aslam, Steff Lewis, Catriona Graham, Audrey C White, Tom MacGillivray, Christopher E Tuck, Phillip Rayson, Denise Cranley, Sian Irvine, Ruth Armstrong, Lynsey Milne, Calvin W L Chin, Graham S Hillis, Timothy Fairbairn, John P Greenwood, Richard Steeds, Stephen J Leslie, Chim C Lang, Chiara Bucciarelli-Ducci, Nikhil V Joshi, Vijay Kunadian, Vassilios S Vassiliou, Jason N Dungu, Sandeep S Hothi, Nicholas Boon, Sanjay K Prasad, Niall G Keenan, Dana Dawson, Thomas A Treibel, Mani Motwani, Christopher A Miller, Nicholas L Mills, Ronak Rajani, David P Ripley, Gerry P McCann, Bernard Prendergast, Anvesha Singh, David E Newby, Marc R Dweck","doi":"10.1001/jama.2024.22730","DOIUrl":"10.1001/jama.2024.22730","url":null,"abstract":"<p><strong>Importance: </strong>Development of myocardial fibrosis in patients with aortic stenosis precedes left ventricular decompensation and is associated with an adverse long-term prognosis.</p><p><strong>Objective: </strong>To investigate whether early valve intervention reduced the incidence of all-cause death or unplanned aortic stenosis-related hospitalization in asymptomatic patients with severe aortic stenosis and myocardial fibrosis.</p><p><strong>Design, setting, and participants: </strong>This prospective, randomized, open-label, masked end point trial was conducted between August 2017 and October 2022 at 24 cardiac centers across the UK and Australia. Asymptomatic patients with severe aortic stenosis and myocardial fibrosis were included. The final date of follow-up was July 26, 2024.</p><p><strong>Intervention: </strong>Early valve intervention with transcatheter or surgical aortic valve replacement or guideline-directed conservative management.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was a composite of all-cause death or unplanned aortic stenosis-related hospitalization in a time-to-first-event intention-to-treat analysis. There were 9 secondary outcomes, including the components of the primary outcome and symptom status at 12 months.</p><p><strong>Results: </strong>The trial enrolled 224 eligible patients (mean [SD] age, 73 [9] years; 63 women [28%]; mean [SD] aortic valve peak velocity of 4.3 [0.5] m/s) of the originally planned sample size of 356 patients. The primary end point occurred in 20 of 113 patients (18%) in the early intervention group and 25 of 111 patients (23%) in the guideline-directed conservative management group (hazard ratio, 0.79 [95% CI, 0.44-1.43]; P = .44; between-group difference, -4.82% [95% CI, -15.31% to 5.66%]). Of 9 prespecified secondary end points, 7 showed no significant difference. All-cause death occurred in 16 of 113 patients (14%) in the early intervention group and 14 of 111 (13%) in the guideline-directed group (hazard ratio, 1.22 [95% CI, 0.59-2.51]) and unplanned aortic stenosis hospitalization occurred in 7 of 113 patients (6%) and 19 of 111 patients (17%), respectively (hazard ratio, 0.37 [95% CI, 0.16-0.88]). Early intervention was associated with a lower 12-month rate of New York Heart Association class II-IV symptoms than guideline-directed conservative management (21 [19.7%] vs 39 [37.9%]; odds ratio, 0.37 [95% CI, 0.20-0.70]).</p><p><strong>Conclusions and relevance: </strong>In asymptomatic patients with severe aortic stenosis and myocardial fibrosis, early aortic valve intervention had no demonstrable effect on all-cause death or unplanned aortic stenosis-related hospitalization. The trial had a wide 95% CI around the primary end point, with further research needed to confirm these findings.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: NCT03094143.</p>","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Jama-Journal of the American Medical Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1